参考文献/References:
[1] K?glmeier J, Day C, Puntis JW. Clinical outcome in patients from a single region who were dependent on parenteral nutrition for 28 days or more. Arch Dis Child, 2008, 93(4):300-302.
[2] Lauriti G, Zani A, Aufieri R, et al. Incidence, prevention, and treatment of parenteral nutrition-associated cholestasis and intestinal failure-associated liver disease in infants and children: a systematic review. JPEN J Parenter Enteral Nutr, 2014, 38(1):70-85.
[3] Yan W, Hong L, Wang Y, et al. Retrospective Dual-Center Study of Parenteral Nutrition-Associated Cholestasis in Premature Neonates: 15 Years' Experience. Nutr Clin Pract, 2017, 32(3):407-413.
[4] Rangel SJ, Calkins CM, Cowles RA, et al. Parenteral nutrition associated cholestasis: an American Pediatric Surgical Association Outcomes and Clinical Trials Committee systematic
review. J Pediatr Surg, 2012, 47(1):225-240.
[5] Lee HH, Jung JM, Nam SH, et al. Risk factor analysis of parenteral nutrition-associated cholestasis in extremely low birth weight infants. Acta Paediatr, 2016, 105(7):e313-e319.
[6] 王 玲. 胃肠外营养相关性胆汁淤积症的治疗. 肠外与肠内营养, 2003, (04): 239-240.
[7] 胡玉莲, 胡长霞 . 早产儿肠外营养相关性肝病的诊断与治疗 .中华实用儿科临床杂志, 2018, 33(19):1454-1459.
[8] Hwang JH, Chung ML. Predictive value of the aspartate aminotransferase to platelet ratio index for parenteral nutrition associated cholestasis in extremely low birth weight infants. BMC Pediatr, 2019, 19(1):126.
[9] Vongbhavit K, Underwood MA. Predictive Value of the Aspartate Aminotransferase to Platelet Ratio Index for Parenteral Nutrition Associated Cholestasis in Premature Infants With Intestinal Perforation. JPEN J Parenter Enteral Nutr, 2018, 42(4):797-804.
[10] Dani C, Pratesi S, Raimondi F, et al. Italian guidelines for the management and treatment of neonatal cholestasis. Italian journal of pediatrics, 2015, 41: 69.
[11] 蔡 威, 汤庆娅, 王 莹, 等. 中国新生儿营养支持临床应用指南. 临床儿科杂志, 2013, 31(12):1177-1182.
[12] Mihatsch WA, Braegger C, Bronsky J, et al. ESPGHAN/ESPEN/ ESPR/CSPEN guidelines on pediatric parenteral nutrition. Clin Nutr, 2018, 37(6 Pt B): 2303-2305.
[13] 谢春艳, 胡景玉, 牟 娜, 等. APRI对慢性乙型肝炎肝脏炎症和纤维化程度的预测性能评价 . 中国免疫学杂志, 2020, 36(2):210-214.
[14] Beath SV, Kelly DA. Total Parenteral Nutrition-Induced Cholestasis: Prevention and Management. Clin Liver Dis, 2016, 20(1):159-176.
[15] Kim AY, Lim RK, Han YM, et al. Parenteral Nutrition-Associated Cholestasis in Very Low Birth Weight Infants: A Single Center Experience. Pediatr Gastroenterol Hepatol Nutr, 2016, 9(1):61-70.
[16] Madnawat H, Welu AL, Gilbert EJ, et al. Mechanisms of Parenteral Nutrition-Associated Liver and Gut Injury. Nutr Clin Pract, 2020, 35(1):63-71.
[17] 周 丽, 徐晓红, 蒋成鹏, 等. 早产儿早期微量喂养预防肠外营养相关性胆汁淤积的Meta分析. 中国妇幼保健, 2019, 34(17):4100-4104.
[18] 陈海燕, 张飞忠, 周 华,等. 早产儿胃肠外营养相关性胆汁淤积的危险因素分析及防治措施. 肠外与肠内营养, 2014, 21(6):352-354,357.
[19] Hsieh MH, Pai W, Tseng HI, et al. Parenteral nutrition-associated cholestasis in premature babies: risk factors and predictors. Pediatr Neonatol, 2009, 50(5):202-207.
[20] 蔡瑞宏, 杨长仪, 修文龙, 等. 中/长链脂肪乳及长链脂肪乳对早产儿静脉营养性胆汁淤积的影响. 中国临床药理学与治疗学, 2017, 22(10):1167-1171.
[21] Wang N, Yan W, Hong L, et al. Risk factors of parenteral nutrition-associated cholestasis in very-low-birthweight infants. J Paediatr Child Health, 2020, 56(11):1785-1790.
[22] 中华医学会肠外肠内营养学分会. 鱼油脂肪乳剂临床应用中国专家共识(2022 版). 中华消化外科杂志, 2022, 21(10): 1313-1325.
[23] 廉晓晓, 钤培国, 郭晓霞. 肝纤维化患者无创诊断模型建立与诊断价值评估.胃肠病学和肝病学杂志, 2017, 26(10):1165-1169.
[24] Suominen JS, Lampela H, Heikkil? P, et al. APRi predicts native liver survival by reflecting portal fibrogenesis and hepatic neovascularization at the time of portoenterostomy in biliary atresia. J Pediatr Surg, 2015, 50(9):1528-1531.
[25] Grieve A, Makin E, Davenport M. Aspartate Aminotransferase-to Platelet ratio index (APRi) in infants with biliary atresia: prognostic value at presentation. J Pediatr Surg, 2013, 48(4):789-795.
[26] 李艳红, 邱 红, 门光国, 等. 血天冬氨酸氨基转移酶与血小板比值在极低/超低出生体重儿肠外营养相关胆汁淤积中的诊断价值. 浙江医学, 2021, 43(13): 1415-1419.